Recently this stock has been exhibiting strength when the Pharma Index
NIFTY PHARMA exhibited heightened weakness losing nearly 800 points. However in
the last two sessions this stock too joined the other Pharma stocks showing
weakness. The pharma sector was pulled down by poor Q1 results of some leading
stocks. However the Q1 performance of Glenpharma itself was much better than expectations.
The stock is still above the support level 691. The volume has also dropped
today though still high. The Up Trend is
still valid and will be till 683 is broken. It will be interesting to see if
the recovery will come soon.
No comments:
Post a Comment